Reston, VA (August 1, 2025)—In a groundbreaking advance for nuclear medicine and molecular imaging, the latest ahead-of-print articles published by...

In a groundbreaking study published in Nature Communications, researchers have unveiled a novel protective mechanism within the kidney’s renal tubular...

In a groundbreaking new study published in Cell Death Discovery, scientists have unveiled the remarkable capacity of panobinostat to amplify...

In an inspiring leap forward for ovarian cancer therapy, recent preclinical research demonstrates that a novel radioimmunotherapy utilizing Terbium-161 (^161Tb)...

In the relentless pursuit of more effective cancer therapies, a novel approach combining palliative irradiation with targeted molecular inhibition is...

In recent years, immunotherapy has revolutionized the treatment landscape for metastatic non-small cell lung cancer (NSCLC), offering hope where traditional...

Pancreatic ductal adenocarcinoma (PDAC) stands as one of the deadliest malignancies globally, notorious for its aggressive invasiveness, late diagnosis, and...

A groundbreaking Phase 3 clinical trial, KEYNOTE-426, has delivered compelling evidence that a combination of pembrolizumab and axitinib significantly enhances...

In the rapidly evolving landscape of medical diagnostics, the intersection of artificial intelligence and imaging technologies is revolutionizing how clinicians...

Cancer-associated fibroblasts (CAFs) have emerged as pivotal players in the complex microenvironment of tumors, orchestrating a multifaceted role that facilitates...